This page lists the SEC filings reported by HealthCap VII, L.P..
Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
---|---|---|---|---|---|---|
SC 13D/A | 2024-05-28 | HealthCap VII, L.P. | Carisma Therapeutics Inc. | 3,398,248 | 8.2% | EDGAR |
SC 13D/A | 2024-03-20 | HealthCap VII, L.P. | Fusion Pharmaceuticals Inc. | 3,807,247 | 4.5% | EDGAR |
SC 13D/A | 2024-03-07 | HealthCap VII, L.P. | Fusion Pharmaceuticals Inc. | 3,807,247 | 5.3% | EDGAR |
SC 13D/A | 2024-03-07 | HealthCap VII, L.P. | Carisma Therapeutics Inc. | 3,398,248 | 8.4% | EDGAR |
SC 13D/A | 2023-03-22 | HealthCap VII, L.P. | Carisma Therapeutics Inc. | 3,398,248 | 8.4% | EDGAR |
SC 13D | 2023-03-09 | HealthCap VII, L.P. | Carisma Therapeutics Inc. | 3,579,611 | 8.9% | EDGAR |
SC 13D/A | 2023-03-06 | HealthCap VII, L.P. | Fusion Pharmaceuticals Inc. | 3,807,247 | 6.1% | EDGAR |
SC 13D/A | 2022-11-15 | HealthCap VII, L.P. | Aprea Therapeutics, Inc. | 2,366,104 | 4.5% | EDGAR |
SC 13D/A | 2022-06-30 | HealthCap VII, L.P. | Aprea Therapeutics, Inc. | 2,366,104 | 10.1% | EDGAR |
SC 13D/A | 2021-10-15 | HealthCap VII, L.P. | Aprea Therapeutics, Inc. | 2,366,104 | 11.2% | EDGAR |
SC 13D | 2020-07-10 | HealthCap VII, L.P. | Fusion Pharmaceuticals Inc. | 3,807,247 | 9.1% | EDGAR |
SC 13D | 2019-10-17 | HealthCap VII, L.P. | Aprea Therapeutics, Inc. | 2,366,104 | 11.9% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.